[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

Re: PD098059 targets



Dear ALL,

I would also be keen to learn if anyone knows of any new information 
regarding the mechanism of action of the  MEK inhibitor PD098059 
developed at Parke-Davis.  

Julia Gee
Tenovus Cancer Research Centre,
UWCM,
Cardiff,
Wales UK